MANUEL
PRAGA TERENTE
Profesor emérito
University Health Network
Toronto, CanadáPublications en collaboration avec des chercheurs de University Health Network (1)
2022
-
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Kidney International, Vol. 101, Núm. 1, pp. 174-184